Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Antibiotic Associated Diarrhoea Including c.Difficile
Interventions: Dietary Supplement: probiotic actimel drink; Dietary Supplement: probiotic placebo drink
Sponsors: University of Sussex; Danone Institute International
Recruiting - verified March 2010
Conditions: Fluid Therapy; Water Electrolyte Imbalance; Acid Base Imbalance
Interventions: Drug: Crystalloid; Drug: Colloid
Sponsor: University of Nottingham
Not yet recruiting - verified March 2010
Conditions: Bladder Cancer; Cervical Cancer; Colorectal Cancer; Endometrial Cancer; Gastrointestinal Complications; Long-term Effects Secondary to Cancer Therapy in Adults; Ovarian Cancer; Prostate Cancer; Radiation Toxicity; Sarcoma; Testicular Germ Cell Tumor; Vaginal Cancer
Interventions: Other: questionnaire administration; Procedure: gastrointestinal complications management/prevention; Procedure: quality-of-life assessment
Sponsor: Royal Marsden NHS Foundation Trust
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: systemic chemotherapy; Procedure: adjuvant therapy; Procedure: quality-of-life assessment; Procedure: therapeutic conventional surgery
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Conditions: Leukemia; Mucositis; Oral Complications
Interventions: Biological: epratuzumab; Biological: palifermin; Biological: rituximab; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: fludarabine phosphate; Drug: imatinib mesylate; Drug: melphalan; Drug: mercaptopurine; Drug: methotrexate; Drug: nelarabine; Drug: pegaspargase; Drug: vincristine sulfate; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: assessment of therapy complications; Radiation: total-body irradiation
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Conditions: Type 2 Diabetes; Hypogonadism
Intervention: Drug: Testosterone
Sponsor: Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified November 2008
Condition: Myocardial Infarction
Intervention:
Sponsors: University of Dundee; NHS Tayside
Active, not recruiting - verified March 2010
Condition: Pulmonary Arterial Hypertension (Idiopathic, Familial or Anorexigen-associated)
Interventions: Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium
Sponsors: University of Alberta; Imperial College London
Enrolling by invitation - verified March 2010
Condition: Cytomegalovirus Infection
Interventions: Biological: Adoptive Cellular Therapy; Drug: Best available antiviral drug therapy
Sponsors: Cell Medica Ltd; Wellcome Trust; Choice Pharma Ltd; Commitum AB; BioAnaLab
Recruiting - verified February 2010
Condition: Cardiac Dysrhythmia
Intervention:
Sponsors: University of Dundee; NHS Tayside
Active, not recruiting - verified March 2010
Condition: Atrail Fibrillation
Intervention:
Sponsors: University of Dundee; NHS Tayside
Active, not recruiting - verified March 2010
Conditions: Fallopian Tube Cancer; Ovarian Cancer
Interventions: Biological: bevacizumab; Drug: capecitabine; Drug: carboplatin; Drug: oxaliplatin; Drug: paclitaxel; Procedure: quality-of-life assessment
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Condition: Breast Cancer Mortality
Intervention: Other: Invitation for breast screening
Sponsors: University of Oxford; Department of Health, United Kingdom
Not yet recruiting - verified March 2010
Condition: Colorectal Cancer
Intervention:
Sponsors: Newcastle University; Northumbria Healthcare NHS Foundation Trust
Recruiting - verified February 2010
Condition: Coronary Artery Disease
Intervention: Device: Radi pressure wire (pressure wire assessment)
Sponsor: Southampton University Hospitals NHS Trust
Recruiting - verified October 2009
Conditions: Cerebral Blood Flow; Cognitive Function
Interventions: Dietary Supplement: DHA-rich fish oil; Dietary Supplement: Placebo
Sponsors: Northumbria University; Ginsana SA
Completed - verified February 2010
Conditions: Cognitive Function; Mood
Interventions: Dietary Supplement: n-3 PUFAs; Dietary Supplement: Placebo; Dietary Supplement: n-3 PUFAs
Sponsors: Northumbria University; Ginsana SA
Completed - verified February 2010
Conditions: Attention; Memory; Mood; Mental Fatigue
Intervention:
Sponsor: Northumbria University
Completed - verified February 2010
Condition: Bacterial Infections
Intervention: Biological: Gut infection challenge with M bovis
Sponsors: St George's, University of London; University of British Columbia; Wellcome Trust; Fundação Ataulpho de Paiva, Rio de Janeiro, Brasil; Foundation for the National Institutes of Health; Bill and Melinda Gates Foundation
Completed - verified February 2010
Condition: Type 1 Diabetes
Interventions: Other: Closed-loop insulin delivery; Other: Standard insulin pump treatment
Sponsors: University of Cambridge; Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting - verified February 2010
Condition: Ischaemia-reperfusion (IR) Injury
Interventions: Drug: C-type natriuretic peptide (CNP); Drug: Saline; Drug: Acetylcholine
Sponsors: Queen Mary University of London; University College, London
Not yet recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: propranolol; Drug: placebo
Sponsors: University of Dundee; Chief Scientist Office of the Scottish Government
Not yet recruiting - verified February 2010
Conditions: HIV; HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
Sponsor: St Stephens Aids Trust
Not yet recruiting - verified February 2010
Conditions: Respiratory Tract Infections; Influenza
Interventions: Dietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil); Dietary Supplement: Miglyol oil
Sponsors: Barts & The London NHS Trust; National Health Service, United Kingdom
Not yet recruiting - verified February 2010
Condition: Hepatitis C
Interventions: Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut
Sponsors: Okairos; University of Oxford
Recruiting - verified February 2010
Conditions: Wegener's Granulomatosis; Microscopic Polyangiitis; Churg Strauss Syndrome; Polyarteritis Nodosa; Giant Cell Arteritis; Takayasu Arteritis
Intervention:
Sponsors: University of Oxford; American College of Rheumatology; The European League Against Rheumatism (EULAR); The Vasculitis foundation
Not yet recruiting - verified February 2010
Condition: Liver Cirrhosis
Intervention:
Sponsors: University College London Hospitals; Medical Research Council
Recruiting - verified April 2008
Condition: Dietary Intervention
Interventions: Dietary Supplement: probiotic; Dietary Supplement: prebiotic; Dietary Supplement: Synbiotic; Dietary Supplement: Placebo
Sponsor: University of Reading
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
Not yet recruiting - verified February 2010
Condition: Paroxysmal Atrial Fibrillation
Interventions: Drug: Dronedarone; Drug: Placebo
Sponsor: Eastbourne General Hospital
Not yet recruiting - verified February 2010
Condition: Asthma
Intervention: Drug: Hydrocortisone/ Placebo and Propranolol
Sponsors: University of Dundee; NHS Tayside
Not yet recruiting - verified December 2009
Condition: Colorectal Cancer
Interventions: Drug: Eicosapentaenoic acid free fatty acid; Drug: Placebo
Sponsor: University of Leeds
Not yet recruiting - verified February 2010
Conditions: Endarterectomy, Carotid; Carotid Stenosis
Intervention: Device: OxyMask
Sponsor: Brighton and Sussex University Hospitals NHS Trust
Recruiting - verified January 2010
Condition: Hypothermia
Intervention: Other: Under patient warming mattress
Sponsor: Brighton and Sussex University Hospitals NHS Trust
Recruiting - verified February 2010
Conditions: Hypothermia; Shivering; Anesthesia, Obstetrical; Anesthesia, Regional; Cesarean Section
Intervention: Device: Warming with warming mattress
Sponsor: Brighton and Sussex University Hospitals NHS Trust
Recruiting - verified November 2009
Condition: HIV Infections
Intervention: Drug: TMC278LA
Sponsor: St Stephens Aids Trust
Recruiting - verified March 2010
Condition: HIV-1
Interventions: Biological: MVA.HIVconsv low dose; Other: Placebo low dose; Biological: MVA.HIVconsv high dose; Other: Placebo high dose
Sponsors: University of Oxford; Medical Research Council
Recruiting - verified December 2009
Condition: Macular Degeneration
Interventions: Device: Epimacular Brachytherapy; Drug: Ranibizumab
Sponsors: King's College Hospital NHS Trust; NeoVista
Recruiting - verified February 2010
Condition: Factor X Deficiency
Intervention: Biological: FACTOR X
Sponsor: Bio Products Laboratory
Not yet recruiting - verified March 2010
Condition: Cancer
Interventions: Biological: adoptive immunotherapy; Biological: alemtuzumab; Biological: in vitro-treated peripheral blood lymphocyte therapy; Drug: foscarnet sodium; Drug: ganciclovir; Genetic: polymerase chain reaction; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: infection prophylaxis and management; Procedure: peripheral blood stem cell transplantation; Procedure: standard follow-up care; Radiation: radiation therapy
Sponsor: University Hospital Birmingham
Recruiting - verified September 2009
Condition: Colorectal Cancer
Interventions: Biological: bevacizumab; Biological: cetuximab; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin; Genetic: RNA analysis; Genetic: cytogenetic analysis; Genetic: fluorescence in situ hybridization; Genetic: gene expression analysis; Genetic: mutation analysis; Genetic: protein expression analysis; Other: diagnostic laboratory biomarker analysis; Other: immunohistochemistry staining method; Other: questionnaire administration; Procedure: cognitive assessment
Sponsor: Medical Research Council
Recruiting - verified February 2010
Condition: Solid Tumors
Intervention: Drug: OXi4503
Sponsors: OXiGENE; Cancer Research UK
Active, not recruiting - verified February 2010
Condition: Hemophilia B
Intervention: Genetic: Gene Transfer
Sponsors: St. Jude Children's Research Hospital; Stanford University; Katharine Dormandy Haemophilia Centre and Haemostasis Unit
Recruiting - verified March 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: mycophenolate mofetil; Other: laboratory biomarker analysis; Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation; Procedure: umbilical cord blood transplantation; Radiation: total-body irradiation
Sponsor: Cancer Research UK
Recruiting - verified August 2009
Conditions: Stroke; Hemispatial Neglect
Interventions: Drug: Guanfacine; Drug: Placebo
Sponsors: Imperial College London; Wellcome Trust
Recruiting - verified March 2010
Condition: Sexually Transmitted Diseases, Viral
Interventions: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads; Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
Sponsors: St George's, University of London; European Union
Active, not recruiting - verified February 2010
Conditions: Hindfoot Arthrodesis; Hindfoot Pathologies
Intervention:
Sponsors: AO Clinical Investigation and Documentation; Synthes Inc.
Recruiting - verified March 2010
Conditions: Atrial Fibrillation; Arrhythmia; Stroke Prevention; Mortality
Interventions: Device: Left atrial ablation; Drug: Rate or Rhythm Control Therapy
Sponsors: Mayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Duke University; St. Jude Medical; Biosense Webster, Inc.
Recruiting - verified February 2010
Condition: Phenylketonuria
Interventions: Dietary Supplement: high oleic sunflower oil; Dietary Supplement: microalgal oil; Dietary Supplement: microalgal oil; Dietary Supplement: microalgal oil; Dietary Supplement: microalgal oil
Sponsors: Ludwig-Maximilians - University of Munich; European Union
Recruiting - verified January 2010
Condition: Sarcoidosis
Interventions: Procedure: EUS-FNA/EBUS-TBNA + BAL; Procedure: EBB + TBLB + BAL
Sponsor: Leiden University Medical Center
Recruiting - verified March 2009
Condition: Bladder Cancer
Interventions: Procedure: therapeutic conventional surgery; Radiation: radiation therapy
Sponsor: Institute of Cancer Research, United Kingdom
Active, not recruiting - verified March 2009
Condition: Acute Coronary Syndrome
Interventions: Drug: Apixaban; Drug: Placebo
Sponsors: Bristol-Myers Squibb; Pfizer; Duke University
Recruiting - verified October 2009
Condition: Cystic Fibrosis
Interventions: Drug: Ataluren (PTC124); Drug: Placebo
Sponsors: PTC Therapeutics; Genzyme; Cystic Fibrosis Foundation
Recruiting - verified March 2010
Conditions: Bladder Cancer; Brain and Central Nervous System Tumors; Esophageal Cancer; Intraocular Melanoma; Kidney Cancer; Lymphoma; Melanoma (Skin); Pancreatic Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Genetic: DNA analysis; Genetic: polymorphism analysis; Other: laboratory biomarker analysis; Other: questionnaire administration
Sponsor: Cancer Research UK
Recruiting - verified September 2008
Conditions: Chemotherapeutic Agent Toxicity; Lymphoma; Mucositis; Neurotoxicity
Interventions: Drug: glucarpidase; Drug: leucovorin calcium; Drug: methotrexate; Other: laboratory biomarker analysis; Procedure: quality-of-life assessment; Radiation: radiation therapy
Sponsor: Cancer Research UK
Recruiting - verified November 2008
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel; Drug: Prasugrel; Drug: Commercially-available Aspirin
Sponsors: Eli Lilly and Company; Daiichi Sankyo Co., Ltd.; Duke University
Recruiting - verified February 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: otelixizumab; Biological: placebo
Sponsors: Tolerx Inc.; Juvenile Diabetes Research Foundation
Active, not recruiting - verified March 2009
Condition: Sarcoma
Intervention: Drug: RG1507
Sponsors: Hoffmann-La Roche; Sarcoma Alliance for Research through Collaboration
Active, not recruiting - verified February 2010
Conditions: Meningococcal Infections; Pneumococcal Infections
Interventions: Biological: NeisVacC (Meningococcal C conjugate vaccine); Biological: Menjugate (Meningococcal C conjugate vaccine)
Sponsors: Health Protection Agency; Institute of Child Health; National Institute of Biological Standards and Control
Recruiting - verified January 2010
Condition: Pain
Interventions: Drug: Placebo; Drug: Pregabalin; Drug: Tramadol SR
Sponsors: Pfizer; University of Oxford
Recruiting - verified March 2010
Condition: Bladder Cancer
Interventions: Procedure: quality-of-life assessment; Procedure: questionnaire administration
Sponsor: University of Birmingham
Recruiting - verified February 2010
Condition: Bladder Cancer
Interventions: Procedure: medical chart review; Procedure: questionnaire administration; Procedure: study of socioeconomic and demographic variables
Sponsor: University of Birmingham
Recruiting - verified February 2010
Condition: Periodic Paralysis
Interventions: Drug: Dichlorphenamide; Drug: Placebo
Sponsors: University of Rochester; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Pelvic Organ Prolapse
Intervention: Procedure: Pelvic Floor Muscle Training
Sponsors: Glasgow Caledonian University; Chief Scientist Office of the Scottish Government; South Glasgow University Hospitals NHS Trust; University of Aberdeen; University of Otago
Active, not recruiting - verified February 2010
Condition: Cancer
Interventions: Genetic: polymerase chain reaction; Other: bronchoalveolar lavage; Other: immunoenzyme technique; Other: laboratory biomarker analysis; Procedure: bronchoscopy; Procedure: management of therapy complications
Sponsor: St. Bartholomew's Hospital
Recruiting - verified September 2007
Conditions: Lymphoma; Neutropenia; Psychosocial Effects of Cancer and Its Treatment; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: amoxicillin-clavulanate potassium; Drug: ciprofloxacin; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
Sponsor: Clatterbridge Centre for Oncology
Recruiting - verified May 2007
Conditions: Mitral Regurgitation; Coronary Artery Disease
Interventions: Procedure: Mitral annuloplasty; Procedure: Coronary Artery Bypass Graft Surgery
Sponsors: Imperial College London; Department of Health, United Kingdom; British Heart Foundation; British Medical Association; Hammersmith Hospitals NHS Trust; St Mary's NHS Trust; King's College Hospital NHS Trust; Glasgow Royal Infirmary; Golden Jubilee National Hospital; University Hospitals, Leicester; Nottingham University Hospitals NHS Trust; Medical University of Silesia; Papworth Hospital; Central Manchester University Hospitals NHS Foundation Trust; United Bristol Healthcare NHS Trust; Blackpool, Flyde and Wyre Hospitals NHS Foundation Trust; Oxford Radcliffe Hospitals NHS Trust
Recruiting - verified March 2010
Condition: Cerebrovascular Accident
Intervention: Other: No intervention
Sponsors: University of Rostock; Shire Human Genetic Therapies, Inc.
Completed - verified February 2010
Conditions: Fabry Disease; Cerebrovascular Accident
Intervention: Other: No intervention
Sponsors: University of Rostock; Shire Human Genetic Therapies, Inc.
Recruiting - verified February 2010
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
Sponsor: Bio Products Laboratory
Terminated - verified March 2010
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
Sponsor: Bio Products Laboratory
Terminated - verified March 2010
Condition: Hemorrhage
Interventions: Drug: Tranexamic acid; Drug: Sodium Chloride 0.9%
Sponsor: London School of Hygiene and Tropical Medicine
Active, not recruiting - verified February 2010
Condition: Breast Neoplasms
Interventions: Drug: CP-751,871 + exemestane; Drug: exemestane
Sponsors: Pfizer; Massachusetts General Hospital
Recruiting - verified March 2010
Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
Interventions: Drug: capecitabine; Other: clinical observation; Procedure: adjuvant therapy
Sponsor: Southampton University Hospitals NHS Trust
Recruiting - verified March 2008
Condition: Lymphoma
Interventions: Biological: pegfilgrastim; Biological: rituximab; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: prednisone; Drug: vincristine sulfate; Other: pharmacological study; Radiation: radiation therapy
Sponsor: German High-Grade Non-Hodgkin's Lymphoma Study Group
Recruiting - verified July 2009
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: AVI-4658 (PMO)
Sponsors: Imperial College London; Department of Health, United Kingdom
Completed - verified February 2010
Condition: Sarcoma
Interventions: Biological: PEG-interferon alfa-2b; Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: methotrexate
Sponsors: Children's Oncology Group; National Cancer Institute (NCI); University College London Hospitals
Recruiting - verified March 2010
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: resveratrol
Sponsors: University of Michigan Cancer Center; National Cancer Institute (NCI)
Completed - verified March 2010
Conditions: Stroke; Transient Ischemic Attack
Interventions: Other: folic acid; Dietary Supplement: Vitamin B6; Dietary Supplement: Vitamin B12
Sponsors: VITATOPS; National Health and Medical Research Council, Australia; National Heart Foundation, Australia; Medical Health Research Infrastructure Council, Australia
Completed - verified February 2010
Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: tamoxifen citrate; Drug: triptorelin; Procedure: oophorectomy; Radiation: radiation therapy
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); Breast International Group; Cancer and Leukemia Group B; NCIC Clinical Trials Group; North Central Cancer Treatment Group; National Surgical Adjuvant Breast and Bowel Project (NSABP); Southwest Oncology Group
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: tamoxifen citrate
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); Breast International Group
Recruiting - verified March 2010
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate; Biological: filgrastim; Biological: pegfilgrastim; Drug: ABVD regimen; Drug: BEACOPP regimen; Drug: cyclophosphamide; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: prednisone; Drug: procarbazine hydrochloride; Drug: vinblastine; Drug: vincristine sulfate
Sponsors: European Organization for Research and Treatment of Cancer; Lymphoma Trials Office; Groupe d'Etudes de Lymphomes de L'Adulte; Grup per l'Estudi dels Limfomes de Catalunya i Balears; NCIC Clinical Trials Group; Australasian Leukaemia and Lymphoma Group (ALLG); Nordic Lymphoma Group
Active, not recruiting - verified June 2009
Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: tamoxifen citrate; Procedure: adjuvant therapy
Sponsor: Cancer Research Campaign Clinical Trials Centre
Active, not recruiting - verified March 2007
Condition: Sarcoma
Interventions: Biological: dactinomycin; Drug: busulfan; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: melphalan; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Procedure: conventional surgery; Radiation: radiation therapy
Sponsors: University Hospitals, Leicester; National Cancer Institute (NCI); Children's Cancer and Leukaemia Group; Societe Francaise Oncologie Pediatrique; European Organization for Research and Treatment of Cancer; Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany; Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria; Swiss Group for Clinical Cancer Research; EBMT Solid Tumors Working Party; Children's Oncology Group
Recruiting - verified March 2010
Condition: Leukemia
Interventions: Drug: asparaginase; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: prednisolone; Drug: prednisone; Drug: thioguanine; Drug: vincristine sulfate; Procedure: allogeneic bone marrow transplantation
Sponsor: Dutch Childhood Oncology Group
Active, not recruiting - verified October 2006
Conditions: Brain and Central Nervous System Tumors; Breast Cancer; Extragonadal Germ Cell Tumor; Infection; Lung Cancer; Lymphoma; Ovarian Cancer; Small Intestine Cancer; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: levofloxacin
Sponsor: Cancer Research Campaign Clinical Trials Centre
Active, not recruiting - verified July 2002
Condition: Prostate Cancer
Interventions: Biological: luteinizing hormone-releasing factor; Radiation: radiation therapy
Sponsor: Medical Research Council
Active, not recruiting - verified July 2001
Condition: Head and Neck Cancer
Interventions: Biological: bleomycin sulfate; Drug: fluorouracil; Drug: leucovorin calcium; Drug: methotrexate; Drug: vincristine sulfate; Radiation: low-LET cobalt-60 gamma ray therapy; Radiation: low-LET photon therapy; Radiation: radiation therapy
Sponsor: Cancer Research UK
Active, not recruiting - verified March 2010
Condition: Endometrial Cancer
Interventions: Procedure: adjuvant therapy; Procedure: conventional surgery; Radiation: brachytherapy; Radiation: radiation therapy
Sponsor: Medical Research Council
Active, not recruiting - verified April 1999
Conditions: Leukemia; Neutropenia
Interventions: Biological: filgrastim; Drug: amsacrine; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: idarubicin; Drug: mitoxantrone hydrochloride; Drug: thioguanine; Drug: tretinoin; Procedure: allogeneic bone marrow transplantation; Procedure: autologous bone marrow transplantation; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy
Sponsor: Medical Research Council
Active, not recruiting - verified October 2002
Condition: Prostate Cancer
Interventions: Drug: bicalutamide; Drug: buserelin; Drug: flutamide; Drug: goserelin; Drug: leuprolide acetate; Drug: nilutamide; Procedure: orchiectomy; Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; Southwest Oncology Group; Medical Research Council
Active, not recruiting - verified March 2010
All Categories ... by University » ... United Kingdom 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
